226 related articles for article (PubMed ID: 15633930)
1. [The occurrence of occult malignancy in patients less than 50 years of age with venous thromboembolism: which diagnostic screening methods to use?].
Malý R; Vodicková L
Vnitr Lek; 2004 Oct; 50(10):751-5. PubMed ID: 15633930
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism and cancer: risks and outcomes.
Lee AY; Levine MN
Circulation; 2003 Jun; 107(23 Suppl 1):I17-21. PubMed ID: 12814981
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of patients hospitalized with venous thromboembolism: comparison between cancer and non-cancer patients.
Kolomansky A; Hoffman R; Sarig G; Brenner B; Haim N
Isr Med Assoc J; 2006 Dec; 8(12):848-52. PubMed ID: 17214102
[TBL] [Abstract][Full Text] [Related]
4. Occult cancer in patients with venous thromboembolism: which patients, which cancers.
Monreal M; Fernandez-Llamazares J; Perandreu J; Urrutia A; Sahuquillo JC; Contel E
Thromb Haemost; 1997 Nov; 78(5):1316-8. PubMed ID: 9408011
[TBL] [Abstract][Full Text] [Related]
5. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
[TBL] [Abstract][Full Text] [Related]
6. [Occult cancer and pulmonary embolism].
Debourdeau P; Farge-Bancel D
Rev Prat; 2007 Apr; 57(7):737-42. PubMed ID: 17626318
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and factors predicting development of venous thromboembolic complications in patients with advanced refractory cancer in a Phase I Clinic: the M. D. Anderson Cancer Center experience.
Vemulapalli S; Chintala L; Tsimberidou AM; Dhillon N; Lei X; Hong D; Kurzrock R
Am J Hematol; 2009 Jul; 84(7):408-13. PubMed ID: 19437507
[TBL] [Abstract][Full Text] [Related]
8. Testing for occult cancer in patients with pulmonary embolism: results from a screening program and a two-year follow-up survey.
Jara-Palomares L; Rodríguez-Matute C; Elías-Hernández T; Rodríguez-Portal JA; López-Campos JL; Garcia-Ibarra H; Barrot-Cortés E; Otero-Candelera R
Thromb Res; 2010 Jan; 125(1):29-33. PubMed ID: 19447476
[TBL] [Abstract][Full Text] [Related]
9. Age, cancer and the risk of venous thromboembolism.
Fimognari FL; Repetto L; Moro L; Gianni W; Incalzi RA
Crit Rev Oncol Hematol; 2005 Sep; 55(3):207-12. PubMed ID: 15979886
[TBL] [Abstract][Full Text] [Related]
10. Screening for occult cancer in patients with acute venous thromboembolism.
Monreal M; Trujillo-Santos J
Curr Opin Pulm Med; 2007 Sep; 13(5):368-71. PubMed ID: 17940478
[TBL] [Abstract][Full Text] [Related]
11. Deep vein thrombosis in primary care: possible malignancy?
Oudega R; Moons KG; Karel Nieuwenhuis H; van Nierop FL; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):693-6. PubMed ID: 16954002
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis.
Schutgens RE; Beckers MM; Haas FJ; Biesma DH
Haematologica; 2005 Feb; 90(2):214-9. PubMed ID: 15710574
[TBL] [Abstract][Full Text] [Related]
13. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
14. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study.
Bova C; Marchiori A; Noto A; Rossi V; Daniele F; Santoro C; Ricchio R; De Lorenzo R; Umbaca R; Prandoni P
Thromb Haemost; 2006 Aug; 96(2):132-6. PubMed ID: 16894454
[TBL] [Abstract][Full Text] [Related]
15. High D-dimer levels at presentation in patients with venous thromboembolism is a marker of adverse clinical outcomes.
Paneesha S; Cheyne E; French K; Bacchu S; Borg A; Rose P
Br J Haematol; 2006 Oct; 135(1):85-90. PubMed ID: 16925794
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
Otten HM; Mathijssen J; ten Cate H; Soesan M; Inghels M; Richel DJ; Prins MH
Arch Intern Med; 2004 Jan; 164(2):190-4. PubMed ID: 14744843
[TBL] [Abstract][Full Text] [Related]
18. Occult malignant neoplasm in patients with deep venous thrombosis.
Goldberg RJ; Seneff M; Gore JM; Anderson FA; Greene HL; Wheeler HB; Dalen JE
Arch Intern Med; 1987 Feb; 147(2):251-3. PubMed ID: 3813741
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism and survival in patients with high-grade glioma.
Simanek R; Vormittag R; Hassler M; Roessler K; Schwarz M; Zielinski C; Pabinger I; Marosi C
Neuro Oncol; 2007 Apr; 9(2):89-95. PubMed ID: 17327573
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
Eriksson H; Lundström T; Wåhlander K; Clason SB; Schulman S;
Thromb Haemost; 2005 Sep; 94(3):522-7. PubMed ID: 16268466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
